{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:32:22Z","timestamp":1792431142534,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005104","name":"Australian Institute of Health and Welfare, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>People in justice settings experience higher rates of psychiatric morbidity, including alcohol and drug use disorders, compared with the general population. However, our understanding of opioid-related harms in justice settings is limited. This study used ambulance data to examine opioid-related harms and experiences of care in New South Wales (NSW), Australia, during periods of incarceration or detention.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This mixed-methods study used data from the National Ambulance Surveillance System (NASS) for patients aged 18 and older with an opioid-related ambulance attendance between December 2020 and April 2023. People in justice settings were identified using ambulance billing codes and manual review of paramedic case notes. Descriptive statistics described the patterns and modalities of opioid-related harms in justice settings, and a qualitative thematic analysis of paramedic case notes was used to contextualise findings. Results Over the study period, 328 opioid-related ambulance attendances for people in justice settings were identified (51% heroin; 41% opioid agonist therapy (OAT) medication). Symptoms of opioid withdrawal were noted in 35% of attendances, most commonly for heroin (51%) and withdrawal from OAT medications (48%). Three interconnected themes were identified using qualitative analysis: trust and mistrust in justice settings, systemic barriers to providing OAT, and other harm reduction strategies, and experiences of withdrawal in justice settings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our study demonstrated the utility of ambulance data in identifying opioid-related harms for people in justice settings in NSW. Qualitative findings highlight current barriers to effective opioid care in justice settings and identify opportunities for intervention, including targeted harm reduction programs, as well as policies that promote continuity of care particularly during transitions in and out of justice settings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12954-025-01154-7","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T16:50:48Z","timestamp":1736959848000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Opioid-related harms and experiences of care among people in justice settings in New South Wales, Australia: evidence from the National Ambulance Surveillance System"],"prefix":"10.1186","volume":"22","author":[{"given":"Naomi","family":"Beard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry M. X.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Hew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaya Mu\u00f1oz","family":"Labiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan I.","family":"Lubman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowan P.","family":"Ogeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"1154_CR1","unstructured":"Biondo S, Young J. Inequalities and inequities experienced by people with mental health and substance use issues involved in the criminal justice system. VAADA & The University of Melbourne; 2019. 2019\/07\/05\/."},{"issue":"5","key":"1154_CR2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1192\/bjp.bp.111.096370","volume":"200","author":"S Fazel","year":"2012","unstructured":"Fazel S, Seewald K. Severe mental illness in 33 588 prisoners worldwide: systematic review and meta-regression analysis. Br J Psychiatry. 2012;200(5):364\u201373.","journal-title":"Br J Psychiatry"},{"issue":"12","key":"1154_CR3","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S2215-0366(17)30430-3","volume":"4","author":"S Fazel","year":"2017","unstructured":"Fazel S, Ramesh T, Hawton K. Suicide in prisons: an international study of prevalence and contributory factors. Lancet Psychiatry. 2017;4(12):946\u201352.","journal-title":"Lancet Psychiatry"},{"issue":"9","key":"1154_CR4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/jvh.12701","volume":"24","author":"E Cunningham","year":"2017","unstructured":"Cunningham E, Hajarizadeh B, Bretana N, Amin J, Betz-Stablein B, Dore G, et al. Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005\u20102014: the HITS\u2010p study. J Viral Hepatitis. 2017;24(9):733\u201341.","journal-title":"J Viral Hepatitis"},{"issue":"10049","key":"1154_CR5","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0140-6736(16)30466-4","volume":"388","author":"K Dolan","year":"2016","unstructured":"Dolan K, Wirtz AL, Moazen B, Ndeffo-Mbah M, Galvani A, Kinner SA, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016;388(10049):1089\u2013102.","journal-title":"Lancet"},{"issue":"5","key":"1154_CR6","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/eurpub\/cku252","volume":"25","author":"L Graham","year":"2015","unstructured":"Graham L, Fischbacher CM, Stockton D, Fraser A, Fleming M, Greig K. Understanding extreme mortality among prisoners: a national cohort study in Scotland using data linkage. Eur J Public Health. 2015;25(5):879\u201385.","journal-title":"Eur J Public Health"},{"issue":"2","key":"1154_CR7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/ije\/dyl225","volume":"36","author":"A Kariminia","year":"2007","unstructured":"Kariminia A, Butler TG, Corben SP, Levy MH, Grant L, Kaldor JM, et al. Extreme cause-specific mortality in a cohort of adult prisoners\u20141988 to 2002: a data-linkage study. Int J Epidemiol. 2007;36(2):310\u20136.","journal-title":"Int J Epidemiol"},{"key":"1154_CR8","volume-title":"Penalties for drug law offences in Europe at a glance","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2019","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. Penalties for drug law offences in Europe at a glance. Lisbon: EMCDDA; 2019. 2019\/05\/13\/."},{"key":"1154_CR9","unstructured":"Enggist S, M\u00f8ller L, Galea G, Udesen C. Prisons and health: World Health Organization. Regional Office for Europe; 2014."},{"key":"1154_CR10","unstructured":"Justice Health Forensic Mental Health Network. People in NSW Public Prisons: 2020 Health Status and Service Utilisation Report. NSW Health; 2022 2022\/11\/\/. Report No.: 1."},{"key":"1154_CR11","unstructured":"Justice Health Forensic Mental Health Network. 2015 Network Patient Health Survey Report. New South Wales, Australia: NSW Health; 2017 2017\/05\/\/. Report No.: 1."},{"issue":"1","key":"1154_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1024\/0939-5911\/a000641","volume":"66","author":"D O\u2019Keefe","year":"2020","unstructured":"O\u2019Keefe D, Ritter A, Stoove M, Hughes C, Dietze P. Harm reduction programs and policy in Australia: barriers and enablers to effective implementation. SUCHT. 2020;66(1):33\u201343.","journal-title":"SUCHT"},{"key":"1154_CR13","doi-asserted-by":"publisher","first-page":"102768","DOI":"10.1016\/j.drugpo.2020.102768","volume":"81","author":"CE Grella","year":"2020","unstructured":"Grella CE, Ostile E, Scott CK, Dennis M, Carnavale J. A scoping review of barriers and facilitators to implementation of medications for treatment of opioid use disorder within the Criminal Justice System. Int J Drug Policy. 2020;81:102768.","journal-title":"Int J Drug Policy"},{"key":"1154_CR14","doi-asserted-by":"publisher","first-page":"102978","DOI":"10.1016\/j.drugpo.2020.102978","volume":"87","author":"R Komalasari","year":"2021","unstructured":"Komalasari R, Wilson S, Haw S. A systematic review of qualitative evidence on barriers to and facilitators of the implementation of opioid agonist treatment (OAT) programmes in prisons. Int J Drug Policy. 2021;87:102978.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"1154_CR15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.idc.2020.06.012","volume":"34","author":"D Winetsky","year":"2020","unstructured":"Winetsky D, Fox A, Nijhawan A, Rich JD. Treating opioid use disorder and related infectious diseases in the Criminal Justice System. Infect Dis Clin N Am. 2020;34(3):585\u2013603.","journal-title":"Infect Dis Clin N Am"},{"key":"1154_CR16","unstructured":"Agramunt S, Lenton S. Evaluation of the western Australian Police Force Naloxone Pilot: a summary of the main findings. National Drug Research Institute; 2023."},{"key":"1154_CR17","unstructured":"Recent overdose deaths. raise fears for people in prison \u2013 naloxone must be made available to save lives [press release]. 2024."},{"key":"1154_CR18","unstructured":"Australian Institute of Health and Welfare. National Opioid Pharmacotherapy Statistics annual data. 2024."},{"key":"1154_CR19","doi-asserted-by":"publisher","first-page":"209066","DOI":"10.1016\/j.josat.2023.209066","volume":"150","author":"AD Marshall","year":"2023","unstructured":"Marshall AD, Schroeder SE, Lafferty L, Drysdale K, Baldry E, Stoov\u00e9 M, et al. Perceived access to opioid agonist treatment in prison among people with a history of injection drug use: a qualitative study. J Subst Use Addict Treat. 2023;150:209066.","journal-title":"J Subst Use Addict Treat"},{"issue":"5","key":"1154_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.5694\/mja2.51854","volume":"218","author":"RJ Winter","year":"2023","unstructured":"Winter RJ, Sheehan Y, Papaluca T, Macdonald GA, Rowland J, Colman A, et al. Consensus recommendations on the management of hepatitis C in Australia\u2019s prisons. Med J Aust. 2023;218(5):231\u20137.","journal-title":"Med J Aust"},{"issue":"3","key":"1154_CR21","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3109\/15563650.2015.1135338","volume":"54","author":"L Fuh","year":"2016","unstructured":"Fuh L, Hays H, Brown N, Shirk MB. Characterization of drug overdoses in an Ohio incarcerated population. Clin Toxicol. 2016;54(3):266\u201370.","journal-title":"Clin Toxicol"},{"key":"1154_CR22","doi-asserted-by":"publisher","first-page":"103131","DOI":"10.1016\/j.drugpo.2021.103131","volume":"92","author":"L McKendy","year":"2021","unstructured":"McKendy L, Biro SM, Miron M, Keown LA. Understanding overdose incidents in Canadian federal custody. Int J Drug Policy. 2021;92:103131.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1154_CR23","doi-asserted-by":"publisher","first-page":"e0228316","DOI":"10.1371\/journal.pone.0228316","volume":"15","author":"DI Lubman","year":"2020","unstructured":"Lubman DI, Matthews S, Heilbronn C, Killian JJ, Ogeil RP, Lloyd B, et al. The National Ambulance Surveillance System: a novel method for monitoring acute alcohol, illicit and pharmaceutical drug related-harms using coded Australian ambulance clinical records. PLoS ONE. 2020;15(1):e0228316.","journal-title":"PLoS ONE"},{"key":"1154_CR24","doi-asserted-by":"crossref","unstructured":"Ogeil RP, Scott D, Faulkner A, Wilson J, Beard N, Smith K et al. Changes in alcohol intoxication-related ambulance attendances during COVID-19: how have government announcements and policies affected ambulance call outs? Lancet Reg Health \u2013 Western Pac. 2021;14.","DOI":"10.1016\/j.lanwpc.2021.100222"},{"issue":"2","key":"1154_CR25","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/add.16360","volume":"119","author":"M McGrath","year":"2024","unstructured":"McGrath M, Stare M, Chua P, Ogeil R, Nehme Z, Scott D, et al. Opioid-related ambulance attendances during the first 2 years of the COVID\u201019 pandemic in Victoria, Australia. Addiction. 2024;119(2):348\u201355.","journal-title":"Addiction"},{"issue":"2","key":"1154_CR26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/02791072.2009.10399907","volume":"41","author":"SG Mitchell","year":"2009","unstructured":"Mitchell SG, Kelly SM, Brown BS, Reisinger HS, Peterson JA, Ruhf A, et al. Incarceration and opioid withdrawal: the experiences of Methadone patients and out-of-treatment heroin users. J Psychoactive Drugs. 2009;41(2):145\u201352.","journal-title":"J Psychoactive Drugs"},{"issue":"7","key":"1154_CR27","doi-asserted-by":"publisher","first-page":"e0236344","DOI":"10.1371\/journal.pone.0236344","volume":"15","author":"DI Lubman","year":"2020","unstructured":"Lubman DI, Heilbronn C, Ogeil RP, Killian JJ, Matthews S, Smith K, et al. National Ambulance Surveillance System: a novel method using coded Australian ambulance clinical records to monitor self-harm and mental health-related morbidity. PLoS ONE. 2020;15(7):e0236344.","journal-title":"PLoS ONE"},{"issue":"2","key":"1154_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qualitative Res Psychol"},{"issue":"3","key":"1154_CR29","doi-asserted-by":"publisher","first-page":"e180558","DOI":"10.1001\/jamanetworkopen.2018.0558","volume":"1","author":"TNA Winkelman","year":"2018","unstructured":"Winkelman TNA, Chang VW, Binswanger IA, Health. Polysubstance Use, and criminal justice involvement among adults with varying levels of opioid use. JAMA Netw Open. 2018;1(3):e180558.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1154_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/dar.12317","volume":"35","author":"N White","year":"2016","unstructured":"White N, Ali R, Larance B, Zador D, Mattick RP, Degenhardt L. The extramedical use and diversion of opioid substitution medications and other medications in prison settings in Australia following the introduction of buprenorphine-naloxone film: use and abuse of medications in prisons. Drug Alcohol Rev. 2016;35(1):76\u201382.","journal-title":"Drug Alcohol Rev"},{"issue":"3","key":"1154_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1360-0443.2011.03676.x","volume":"107","author":"D Hedrich","year":"2012","unstructured":"Hedrich D, Alves P, Farrell M, St\u00f6ver H, M\u00f8ller L, Mayet S. The effectiveness of opioid maintenance treatment in prison settings: a systematic review: opioid maintenance in prison. Addiction. 2012;107(3):501\u201317.","journal-title":"Addiction"},{"issue":"Supplement3","key":"1154_CR32","doi-asserted-by":"publisher","first-page":"ckac131416","DOI":"10.1093\/eurpub\/ckac131.416","volume":"32","author":"S Mazzilli","year":"2022","unstructured":"Mazzilli S, Royuela L, Tavoschi L, Vandam L, Montanari L. Prevalence of injected drug use and access to OAT in prison: survey in 7 EU countries, 2014\u20132018. Eur J Pub Health. 2022;32(Supplement3):ckac131416.","journal-title":"Eur J Pub Health"},{"issue":"4","key":"1154_CR33","doi-asserted-by":"publisher","first-page":"e004666","DOI":"10.1136\/bmjopen-2013-004666","volume":"4","author":"S Larney","year":"2014","unstructured":"Larney S, Gisev N, Farrell M, Dobbins T, Burns L, Gibson A, et al. Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study. BMJ Open. 2014;4(4):e004666.","journal-title":"BMJ Open"},{"issue":"5","key":"1154_CR34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/emermed-2022-212755","volume":"40","author":"M Curtis","year":"2023","unstructured":"Curtis M, Wilkinson AL, Dietze P, Stewart AC, Kinner SA, Cossar RD, et al. Prospective study of retention in opioid agonist treatment and contact with emergency healthcare following release from prisons in Victoria, Australia. Emerg Med J. 2023;40(5):347\u201354.","journal-title":"Emerg Med J"},{"issue":"8","key":"1154_CR35","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/add.13779","volume":"112","author":"J Marsden","year":"2017","unstructured":"Marsden J, Stillwell G, Jones H, Cooper A, Eastwood B, Farrell M, et al. Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England: prison-based OST and mortality after release. Addiction. 2017;112(8):1408\u201318.","journal-title":"Addiction"},{"issue":"1","key":"1154_CR36","doi-asserted-by":"publisher","first-page":"2094111","DOI":"10.1080\/17482631.2022.2094111","volume":"17","author":"C Russell","year":"2022","unstructured":"Russell C, Pang M, Nafeh F, Farrell Macdonald S, Derkzen D, Rehm J, et al. Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada. Int J Qualitative Stud Health Well-being. 2022;17(1):2094111.","journal-title":"Int J Qualitative Stud Health Well-being"},{"issue":"11","key":"1154_CR37","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1017\/S0033291711000705","volume":"41","author":"N Humber","year":"2011","unstructured":"Humber N, Piper M, Appleby L, Shaw J. Characteristics of and trends in subgroups of prisoner suicides in England and Wales. Psychol Med. 2011;41(11):2275\u201385.","journal-title":"Psychol Med"},{"key":"1154_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-019-0340-4","volume":"16","author":"H St\u00f6ver","year":"2019","unstructured":"St\u00f6ver H, Jamin D, Michels II, Knorr B, Keppler K, Deimel D. Opioid substitution therapy for people living in German prisons\u2014inequality compared with civic sector. Harm Reduct J. 2019;16:1\u20139.","journal-title":"Harm Reduct J"},{"key":"1154_CR39","unstructured":"International Covenant on Economic. Social and Cultural Rights, (1966)."},{"issue":"6","key":"1154_CR40","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1081\/JA-200030795","volume":"40","author":"W Small","year":"2005","unstructured":"Small W, Kain S, Laliberte N, Schechter MT, O\u2019Shaughnessy MV, Spittal PM. Incarceration, addiction and harm reduction: inmates experience injecting drugs in prison. Subst Use Misuse. 2005;40(6):831\u201343.","journal-title":"Subst Use Misuse"},{"issue":"1","key":"1154_CR41","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/epirev\/mxx019","volume":"40","author":"JV Lazarus","year":"2018","unstructured":"Lazarus JV, Safreed-Harmon K, Hetherington KL, Bromberg DJ, Ocampo D, Graf N, et al. Health Outcomes for Clients of Needle and syringe programs in prisons. Epidemiol Rev. 2018;40(1):96\u2013104.","journal-title":"Epidemiol Rev"},{"issue":"1","key":"1154_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12954-015-0045-2","volume":"12","author":"C Treloar","year":"2015","unstructured":"Treloar C, McCredie L, Lloyd AR. On behalf of the H-pi. Acquiring hepatitis C in prison: the social organisation of injecting risk. Harm Reduct J. 2015;12(1):10.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1154_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/jvh.13895","volume":"31","author":"B Hajarizadeh","year":"2024","unstructured":"Hajarizadeh B, Carson JM, Byrne M, Grebely J, Cunningham E, Amin J, et al. Incidence of hepatitis C virus infection in the prison setting: the SToP-C study. J Viral Hepatitis. 2024;31(1):21\u201334.","journal-title":"J Viral Hepatitis"},{"issue":"3","key":"1154_CR44","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/add.14012","volume":"113","author":"L Platt","year":"2018","unstructured":"Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, et al. Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis. Addiction. 2018;113(3):545\u201363.","journal-title":"Addiction"},{"key":"1154_CR45","unstructured":"Kinder S. Ethic justice: needle and syringe programs in Australian prisons. Med J Aust. 2020(16)."},{"issue":"2","key":"1154_CR46","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/09595239800186951","volume":"17","author":"KA Dolan","year":"1998","unstructured":"Dolan KA, Wodak AD, Hall WD. Methadone maintenance treatment reduces heroin injection in New South Wales prisons. Drug Alcohol Rev. 1998;17(2):153\u20138.","journal-title":"Drug Alcohol Rev"},{"key":"1154_CR47","doi-asserted-by":"publisher","first-page":"103572","DOI":"10.1016\/j.drugpo.2021.103572","volume":"100","author":"M Curtis","year":"2022","unstructured":"Curtis M, Berk J, Larney S, Rich JD, Stoov\u00e9 M. Switching of opioid agonist treatment modality during imprisonment: a novel marker for increased support need during and following release from prison. Int J Drug Policy. 2022;100:103572.","journal-title":"Int J Drug Policy"},{"key":"1154_CR48","doi-asserted-by":"publisher","unstructured":"Beard N, McGrath M, Scott D, Nehme Z, Lubman DI, Ogeil RP. Using ambulance surveillance data to characterise blood-borne viral infection histories among patients presenting with acute alcohol and other drug\u2010related harms. Emerg Med Australasia. 2024 Aug;36(4):536\u2013542. https:\/\/doi.org\/10.1111\/1742-6723.14394. Epub 2024 Feb 28","DOI":"10.1111\/1742-6723.14394"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01154-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01154-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01154-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T16:50:55Z","timestamp":1736959855000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01154-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1154"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01154-7","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}